MPH HEALTH CARE AG KONV (93M1.DE) Stock Price & Overview

FRA:93M1 • DE000A289V03

Current stock price

20.5 EUR
+0.55 (+2.76%)
Last:

The current stock price of 93M1.DE is 20.5 EUR. Today 93M1.DE is up by 2.76%. In the past month the price increased by 9.02%. In the past year, price decreased by -15.82%.

93M1.DE Key Statistics

52-Week Range15.8 - 29.4
Current 93M1.DE stock price positioned within its 52-week range.
1-Month Range17.7 - 20.6
Current 93M1.DE stock price positioned within its 1-month range.
Market Cap
87.74M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-26.91
Dividend Yield
6.19%

93M1.DE Stock Performance

Today
+2.76%
1 Week
+3.64%
1 Month
+9.02%
3 Months
-18.24%
Longer-term
6 Months +10.53%
1 Year -15.82%
2 Years -4.09%
3 Years +26.27%
5 Years -28.49%
10 Years N/A

93M1.DE Stock Chart

MPH HEALTH CARE AG KONV / 93M1 Daily stock chart

93M1.DE Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to 93M1.DE. When comparing the yearly performance of all stocks, 93M1.DE is a bad performer in the overall market: 89.98% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

93M1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to 93M1.DE. The financial health of 93M1.DE is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

93M1.DE Earnings

Next Earnings DateMay 27, 2026
Last Earnings DateNov 20, 2025
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

93M1.DE Forecast & Estimates


Analysts
Analysts85.71
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

93M1.DE Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

93M1.DE Financial Highlights

Over the last trailing twelve months 93M1.DE reported a non-GAAP Earnings per Share(EPS) of -26.91. The EPS decreased by -196.45% compared to the year before.


Income Statements
Revenue(TTM)52.00K
Net Income(TTM)-115.23M
Industry RankSector Rank
PM (TTM) N/A
ROA -52.66%
ROE -56.18%
Debt/Equity 0.02
Chartmill High Growth Momentum
EPS Q2Q%-197.62%
Sales Q2Q%166.92%
EPS 1Y (TTM)-196.45%
Revenue 1Y (TTM)104.72%

93M1.DE Ownership

Ownership
Inst Owners1.08%
Shares4.28M
Float1.71M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About 93M1.DE

Company Profile

93M1 logo image MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. The company is headquartered in Berlin, Berlin and currently employs 2 full-time employees. The company went IPO on 2009-01-01. The firm focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The firm's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.

Company Info

IPO: 2009-01-01

MPH HEALTH CARE AG KONV

Gruenauer Strasse 5

Berlin BERLIN DE

Employees: 2

93M1 Company Website

93M1 Investor Relations

Phone: 4930863214560

MPH HEALTH CARE AG KONV / 93M1.DE FAQ

Can you describe the business of MPH HEALTH CARE AG KONV?

MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. The company is headquartered in Berlin, Berlin and currently employs 2 full-time employees. The company went IPO on 2009-01-01. The firm focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The firm's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.


What is the current price of 93M1 stock?

The current stock price of 93M1.DE is 20.5 EUR. The price increased by 2.76% in the last trading session.


Does 93M1 stock pay dividends?

MPH HEALTH CARE AG KONV (93M1.DE) has a dividend yield of 6.19%. The yearly dividend amount is currently 0.


What is the ChartMill technical and fundamental rating of 93M1 stock?

93M1.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


On which exchange is 93M1.DE stock listed?

93M1.DE stock is listed on the Frankfurt Stock Exchange exchange.


Should I buy 93M1 stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 93M1.DE.